LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Findings Implicate Circular RNA in the Development of Neurodegenerative Diseases

By LabMedica International staff writers
Posted on 28 Sep 2014
Print article
Image: Formation of circRNA—in this case circMbl—competes with the process of linear splicing (Photo courtesy of The Hebrew University of Jerusalem).
Image: Formation of circRNA—in this case circMbl—competes with the process of linear splicing (Photo courtesy of The Hebrew University of Jerusalem).
A recent paper described new findings that shed light on the production and function of circular RNA molecules (circRNA) in animal neuronal tissue.

CircRNA is a type of noncoding RNA that, unlike linear RNA, forms a covalently closed continuous loop. In circular RNA the 3' and 5' ends normally present in an RNA molecule have been joined together. This feature confers numerous properties to circular RNAs, many of which have only recently been identified. Though many of these circular RNAs arise from otherwise protein coding genes, circular RNAs produced in the cell have not been shown to code for proteins.

Investigators at The Hebrew University of Jerusalem (Israel) reported in the September 18, 2014, online edition of the journal Molecular Cell that animal circRNAs were generated co-transcriptionally and that their production rate was mainly determined by intronic sequences—filler DNA that separates coding regions on the chromosomes.

The investigators demonstrated that the process of circularization and that of normal splicing competed against each other, and that these mechanisms were tissue specific and conserved in animals. To further refine these findings, they concentrated on the gene for the protein muscleblind (muscleblind-like splicing regulator 1), which generates circularized RNA in flies and humans. They found that this circRNA (circMbl) and its flanking introns contained conserved muscleblind binding sites, which were strongly and specifically bound by muscleblind. Modulation of muscleblind levels strongly affected circMbl biosynthesis, and this effect was dependent on the muscleblind binding sites.

Since defects in muscleblind function have been linked to the severe degenerative disease myotonic dystrophy and since high levels of circRNAs are found in brain tissue, it may be that these molecules play a role in development of myotonic dystrophy and possibly other neurodegenerative diseases.

Senior author Dr. Sebastian Kadener, senior lecturer in biological chemistry at The Hebrew University of Jerusalem, said, "This research is significant from several perspectives. By mapping how circRNAs are produced, it helps advance our understanding of general molecular biology. In addition, it might be strongly relevant for understanding and eventually treating degenerative diseases both in muscle and the brain."

Related Links:

The Hebrew University of Jerusalem


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more